PharmaRoth Labs, Inc. Share Price Other OTC
Equities
ROTH
US71715Y1029
Pharmaceuticals
Sales 2009 | - | Sales 2010 | - | Capitalization | 5.74M 458M |
---|---|---|---|---|---|
Net income 2009 | - 0 | Net income 2010 | - 0 | EV / Sales 2009 | - |
Net Debt 2009 | 12.5K 997K | Net Debt 2010 | 286K 22.84M | EV / Sales 2010 | - |
P/E ratio 2009 |
-777
x | P/E ratio 2010 |
-7.8
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 30.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/08/10 | |
Barry W. Hall
DFI | Director of Finance/CFO | 76 | 21/01/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/08/10 |
1st Jan change | Capi. | |
---|---|---|
+34.04% | 664B | |
+28.25% | 567B | |
-6.82% | 354B | |
+19.40% | 330B | |
+3.20% | 286B | |
+13.51% | 234B | |
+4.87% | 199B | |
-10.35% | 196B | |
-5.44% | 148B |